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Outcomes after endarterectomy for chronic
mesenteric ischemia
Matthew W. Mell, MD, Charles W. Acher, MD, John R. Hoch, MD, Girma Tefera, MD, and
William D. Turnipseed, MD, Madison, Wis
Objectives:A retrospective study was performed to identify optimal factors affecting outcomes after open revascularization
for chronic mesenteric ischemia.
Methods: All patients who underwent open surgery for chronic mesenteric ischemia from 1987 to 2006 were reviewed.
Patients with acute mesenteric ischemia or median arcuate ligament syndrome were excluded. Mortality, recurrent
stenosis, and symptomatic recurrence were analyzed using logistic regression, and univariate and multivariate analysis.
Results:We identified 80 patients (69% women, 31%men). Mean age was 64 years (range, 31-86 years). Acute-on-chronic
symptoms were present in 26%. Presenting symptoms included postprandial pain (91%), weight loss (69%), and food fear
and diarrhea (25%). Preoperative imaging demonstrated severe (>70%) stenosis of the superior mesenteric artery in 75
patients (24 occluded), the celiac axis in 63 (20 occluded), and the inferior mesenteric artery in 53 (20 occluded).
Multivessel disease was present in 72 patients (90%), and 40 (50%) underwent multivessel reconstruction. Revascular-
ization was achieved by endarterectomy in 37 patients, mesenteric bypass in 29, and combined procedures in 14.
Concurrent aortic reconstruction was required in 13 patients (16%). Three hospital deaths occurred (3.8%). Mean
follow-up was 3.8 years (range, 0-17.2 years). One- and 5-year survival was 92.2% and 64.5%. Mortality was associated
with age (P .019) and renal insufficiency (P .007), but not by clinical presentation. Symptom-free survival was 89.7%
and 82.1% at 1 and 5 years, respectively. Symptoms requiring reintervention occurred in nine patients (11%) at a mean of
29 months (range, 5-127 months). Multivariate analysis showed that freedom from recurrent symptoms correlated with
endarterectomy for revascularization (5.2% vs 27.6%; hazard ratio, 0.20; 95% confidence interval, 0.04-0.92; P  .02).
Conclusion: For open surgical candidates, endarterectomy appears to provide the most durable long-term symptom relief
in patients with chronic mesenteric ischemia. (J Vasc Surg 2008;48:1132-8.)Chronic mesenteric ischemia (CMI) remains an un-
common yet important cause of chronic abdominal pain.
The goal of treatment for CMI is a safe and effective
revascularization that provides the patient with immediate
and durable relief of symptoms, minimal procedural risk,
and protection from morbidity and mortality associated
with intestinal ischemia.
Optimal treatment for patients with CMI remains con-
troversial and challenging. Open surgical revascularization
is still considered the standard of care, but may be associ-
ated with significant morbidity and mortality.1-12 Percuta-
neous approaches have been suggested to play an increased
role in the treatment of CMI because of high initial tech-
nical success and low morbidity13-16; however, they have
been associated with poor long-term patency and a high
rate of recurrent symptoms requiring reintervention.
Many different approaches to operative revasculariza-
tion have been described, including local endarterectomy,
transaortic endarterectomy, and surgical bypass. For by-
passes, antegrade (supraceliac aorta) and retrograde (distal
aorta, iliac artery) inflow sources have been reported, with
outflow to one or multiple visceral arteries. Short-term and
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1132long-term data demonstrate good results for open surgical
bypass but long-term outcomes are limited when comparing
endarterectomy with surgical bypass for treatment of CMI.
The goals of this study were to define our institutional
experience with open surgical treatment of CMI and to
determine if endarterectomy or surgical bypass was associ-
ated with improved short-term or long-term outcomes.
METHODS
The Institutional Review Board of the University of
Wisconsin Hospital and Clinics approved the research pro-
tocol. Clinical data were collected from medical records for
all patients who underwent visceral revascularization for
CMI at the University of Wisconsin Hospital from 1987 to
2006. Inclusion criteria included patients with chronic
CMI symptoms and patients who presented with acute or
subacute symptoms in the presence of ongoing chronic
symptoms. Patients who underwent visceral revasculariza-
tion in conjunction with aortic reconstruction were in-
cluded only if they had symptoms of CMI. Patients with
acute mesenteric ischemia without a history of CMI were
excluded, as were those with median arcuate ligament
syndrome and asymptomatic visceral occlusive disease.
Data collected included demographic information, co-
morbidities (hypertension, cardiac disease, chronic renal
insufficiency, chronic obstructive lung disease, diabetes
mellitus, hyperlipidemia, smoking, previous vascular sur-
gery), presenting symptoms (postprandial pain, unplanned
weight loss, nausea, vomiting, diarrhea), extent of disease,
operative revascularization, short-term outcomes, and
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angina, congestive heart failure, or a history of myocardial
infarction or coronary revascularization. Renal insufficiency
was defined as serum creatinine 1.5 mg/dL. The Social
Security Death Index online database was queried to cap-
ture all deaths.
The extent of disease was based on radiographic infor-
mation available for each patient. Accepted imagingmodal-
ities included angiography, computed tomography angiog-
raphy, or magnetic resonance angiography. Occlusive
disease was defined as 70% stenosis or occlusion. Data
included the number and pattern of vessels involved as well
as the extent of disease (stenosis vs occlusion) in each vessel.
Operative details included the number of arteries revascu-
larized and type of reconstruction (endarterectomy with or
without reimplantation, or bypass). For patients undergo-
ing bypass, type of conduit (autologous, Dacron, polytet-
rafluoroethylene) and directionality (antegrade or retro-
grade) was recorded.
Patients were divided into three groups: endarterec-
tomy, bypass, and combined procedures. Combined pro-
cedures were those in which revascularization was achieved
with endarterectomy of at least one visceral artery, with
bypass to one other visceral artery. Endarterectomy of the
inflow or outflow vessel as part of a bypass procedure was
included in the bypass group. The choice of procedure was
determined by the acuity of presentation, presence of ne-
crotic bowel, severity of disease, the number of arteries
amenable to revascularization, and surgeon preference.
Perioperative outcome variables included 30-day and
inpatient mortality, major morbidity, minor morbidity, and
hospital stay. Major morbidity included myocardial infarc-
tion, stroke, acute renal failure, respiratory failure, or bowel
infarction. Minor morbidity was defined as other complica-
tions requiring further treatment or hospitalization.
Long-term outcome variables included 5-year survival,
recurrent stenosis, recurrent symptoms, and repeat inter-
vention. Recurrent stenosis was defined as radiographic
evidence of 70% stenosis of a treated artery, with or
Table I. Patient demographics and disease pattern by repa
Variable Endarterectomy (n  37)
Age, mean years 66
Female gender, No. (%) 22 (58)
Tobacco history, No. (%) 26 (70)
Diabetes mellitus, No. (%) 2 (5)
Cardiac disease, No. (%) 16 (43)
Hypertension, No. (%) 30 (81)
Hyperlipidemia, No. (%) 15 (41)
Renal insufficiency, No. (%) 4 (11)
Previous surgery, No. (%) 9 (24)
COPD, No. (%) 8 (22)
Diseased arteries, mean 2.34
Occluded arteries, mean 1.34
Arteries treated, mean 1.76
COPD, Chronic obstructive pulmonary disease.without the presence of symptoms. Recurrent symptomsincluded all patients whose preoperative symptoms re-
curred after revascularization. Repeat intervention was de-
fined as any subsequent procedure performed for either
recurrent stenosis or symptoms of recurrent CMI.
Statistical analysis was performed on demographic, op-
erative, and outcome variables. Measured values were re-
ported as percentages or mean  standard deviation. Sur-
vival, freedom from recurrent symptoms, freedom from
recurrent stenosis, and freedom from reintervention were
analyzed using the Kaplan-Meier method. Univariate analysis
of demographic and operative variables with respect to out-
come measures was performed with 2, the Fisher exact test,
or t tests where appropriate. Multivariate stepwise regression
analysis was done of of covariates significantly (P  .05)
associated with outcomes. Analyses were performed using
SAS 8.2 software (SAS Institute, Cary, NC).
RESULTS
We identified 80 patients (69% women, 31% men).
Demographics of patients undergoing endarterectomy, by-
pass, or combined procedures are noted in Table I. Mean
age was 64  13 years (range, 31-86 years). Acute-on-
chronic symptoms were present in 26%. Presenting symp-
toms included postprandial pain (91%), weight loss (69%),
and food fear and diarrhea (25%). Intestinal infarction was
present in four (5%) patients. Preoperative imaging dem-
onstrated severe (70%) stenosis of the superiormesenteric
artery in 75 patients (24 occluded), the celiac axis in 63 (20
occluded), and the inferior mesenteric artery in 53 (20
occluded). The number of diseased and occluded arteries
was similar among the groups (Table I). Multivessel disease
was present in 72 patients (90%; Table II).
Revascularization was achieved by endarterectomy in
37 patients (34 transaortic endarterectomy, 3 local endar-
terectomy), visceral artery bypass in 29, and combined
procedures in 14 (Table III). A total of 134 arteries were
treated, with 40 patients (50%) undergoing multivessel
reconstruction, and 19 of 72 patients with multivessel
pe
Bypass (n  29) Combined (n  14) P
62 60 .40
23 (79) 10 (77) .15
20 (71) 7 (54) .57
1 (4) 0 (0) .98
6 (21) 7 (54) .08
18 (64) 11 (85) .23
8 (29) 4 (31) .57
2 (7) 1 (8) .86
10 (34) 5 (38) .49
10 (36) 4 (31) .44
2.25 2.84 .07
1.17 1.38 .65
1.44 2.07 .003ir tydisease undergoing single-vessel reconstruction.
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was determined by the acuity of presentation, presence of
necrotic bowel, extent of disease of each vessel, the suitabil-
ity of a target vessel, and surgeon preference. Concurrent
aortic reconstruction was required in 13 patients (16%).
Bypass conduits included Dacron in 14, polytetrafluoro-
ethylene in 13, and autologous tissue in 16. Antegrade
bypass was performed in 23 patients, and retrograde in 20.
Mean intensive care unit (ICU) stay was 4.5 4.5 days,
and mean hospital stay was 17  15 days. Three deaths
occurred30 days or during the index hospitalization, for
a perioperative inpatient mortality of 3.8%. One death was
secondary to respiratory failure and pneumonia, one was
from a myocardial infarction, and one occurred as a conse-
quence of extensive visceral gangrene with a patent ante-
grade bypass. No clinical or operative factors predicted
perioperative mortality.
Overall morbidity was 26.3%, with major events occur-
ring in 11 of 80 (13.8%, Table IV). A logistic regression
model showed that age (hazard ratio [HR], 1.08; 95%
confidence interval [CI], 1.02-1.14; P .01), the presence
of acute-on-chronic symptoms (HR, 5.0; 95% CI, 1.38-
17.24; P  .02), and concurrent aortic occlusive disease
(HR, 4.8; 95% CI, 1.09-21.74; P .05), but not aneurys-
mal disease, were each independent predictors of major
morbidity. Symptoms were relieved in 75 patients (93%).
Of the 54 patients who presented with weight loss, 52
(96%) regained some or all of the weight.
Mean follow-up was 46 months (range, 1-206 months).
Table II. Distribution of visceral disease by patient
Vessel No.
CA, SMA, IMA 43
CA, SMA 19
CA, IMA 2
SMA, IMA 8
CA only 2
SMA only 6
IMA only 0
CA, Celiac axis; IMA, inferior mesenteric artery; SMA, superior mesenteric
artery.
Table III. Repair type by vessels revascularized
Vessel treated
Repair type
Endarterectomy Bypass Combined
CA, SMA, IMA 4 0 3
CA, SMA 22 13 7
CA, IMA 0 0 1
SMA, IMA 0 0 3
CA only 0 5 0
SMA only 11 11 0
IMA only 0 0 0
CA, Celiac axis; IMA, inferior mesenteric artery; SMA, superior mesenteric
artery.Clinical follow-up was available for all patients. Estimatedoverall survival was 92.2%, 72.0%, and 64.5% at 1, 3, and 5
years. Age (P  .01), chronic renal insufficiency (P  .01),
and chronic obstructive pulmonary disease (P  .05) were
associated with late mortality by univariate analysis; age
(HR, 1.05; 95% CI, 1.01-1.09, P  0.02) and renal insuf-
ficiency (HR, 3.87; 95% CI, 1.45-10.31; P  0.01) re-
mained independent predictors of mortality by multivariate
analysis. There was a trend toward improved estimated
5-year survival for patients without acute-on-chronic symp-
toms, although this did not reach statistical significance
(69% vs 50%, P  .07).
Recurrent symptoms developed in 11 patients (13.8%),
consisting of eight (28%) after surgical bypass, three (8%)
after endarterectomy, and one (7%) after a combined pro-
cedure. For these patients, mean time to symptom recur-
rence was 28 months (range, 1-127 months). Estimated
symptom-free survival was 89.7%, 85.6%, and 82.1% at 1, 3,
and 5 years, respectively. Both univariate and multivariate
analysis demonstrated endarterectomy (HR, 0.20; 95% CI,
0.04-0.92; P  .04) to be inversely associated with recur-
rent symptoms (Table V). Extent of disease, number of
occluded vessels, and number of vessels treated were not
associated with symptom recurrence. By life-table analysis,
freedom from recurrence at 2 years was estimated at 79% for
the bypass group vs 95% for those undergoing endarterec-
tomy and 92% for combined procedures (P  .03; Fig 1).
Follow-up radiographic data were available for 56 of 80
patients (70%), of whom 14 had documented70% recur-
rent stenosis or occlusion and 11 were symptomatic. Re-
current stenosis occurred in three patients after endarterec-
tomy, 10 patients after surgical bypass, and one patient after
a combined procedure. Freedom from recurrent stenosis
was estimated at 91%, 80%, and 75% at 1, 3, and 5 years. No
factors were independently associated with recurrent steno-
sis but there was a trend toward decreased recurrent steno-
sis for patients undergoing endarterectomy. Two-year esti-
mates of recurrent stenosis were 79% for the bypass group
and 88% for the endarterectomy and combined treatment
groups (P  .13; Fig 2).
Nine patients with recurrent symptoms and docu-
Table IV. Complications of open repair
Morbidity Frequency (%)
Cardiac 2 (2.5)
Bowel infarction 2 (2.5)
Stroke 1 (1.3)
Renal failure 2 (2.5)
Respiratory failure 4 (5.0)
Cholangitis 1 (1.3)
Dehiscence 1 (1.3)
Deep vein thrombosis 2 (2.5)
Arterial occlusion 1 (1.3)
Pancreatitis 1 (1.3)
Pseudoaneurysm 1 (1.3)
Graft thrombosis 1 (1.3)
Splenic abscess 1 (1.3)
Total 21 (26.3)mented recurrent disease had reintervention at a mean of
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recurrent symptoms did not undergo repeat intervention.
One patient had mild symptoms with a recurrent stenosis
after surgical bypass; symptoms resolved with observation.
The other patient refused treatment.
Estimated freedom from repeat intervention was 96%,
Table V. Analysis of factors associated with recurrent
symptoms
Variable HR (95% CI) P
Univariate analysis
Age .002
Smoking .22
Diabetes mellitus .99
Renal failure .99
Hyperlipidemia .77
Cardiac history .54
Hypertension .06
Acute symptoms .14
Endarterectomy .003
Number of diseased vessels .14
Occluded vessels .09
Number of vessels repaired .94
Aortic reconstruction .99
Directionality of bypass .47
Type of conduit .10
Multivariate analysis
Age 0.94 (0.90-0.99) .01
Endarterectomy 0.20 (0.04-0.92) .04
CI, Confidence interval; HR, hazard ratio.
p = 0.003
Bypass
Number at Risk
Endarterectomy             37                   21                  15                   15                   13                    8
Bypass         29                   20                  13                   10                    7                      6
Combined                        14                   12                  11                    9                      6                     6
           Years Following Procedure 0                   1                  2                   3                   4                   5
Fig 1. Kaplan-Meier estimates of freedom fromrecurrent symptoms
after open repair for mesenteric ischemia with endarterectomy (blue
line), bypass (red line), and combined procedures (green line).88%, and 85% at 1, 3 and 5 years; no statistical differencewas identified when comparing endarterectomy, surgical
bypass, and combined procedures (P .22; Fig 3). Increas-
ing age (P  .01), acute symptoms (P  .05), and total
occlusion of visceral arteries (P .05) were associated with
repeat intervention by univariate analysis; only age was an
independent factor by multivariate analysis (HR 0.94, 95%
CI 0.88-0.99; P  .036; Table VI).
DISCUSSION
Although asymptomatic visceral arterial stenosis is a
common occurrence,1 CMI is a rare clinical entity. The
exact incidence is unknown, but treatment for CMI has
been estimated to comprise 1% of vascular procedures
performed.2 Vague symptoms can delay diagnosis, al-
though postprandial pain and weight loss are common and
may be present in up to 90% of patients.3 Undiagnosed
CMI results in severe nutritional depletion, and may
progress to acute mesenteric ischemia and intestinal infarc-
tion. Emergency operation for acute mesenteric ischemia is
associated with a mortality of up to 60%.4,5
Open surgical repair has remained the standard of
therapy for CMI. Because of its uncommon and varied
presentation, no consensus exists about the optimal surgi-
cal approach. Discussion has centered on the type of repair
(endarterectomy vs bypass), the number of arteries revas-
cularized, the directionality of bypass (antegrade vs retro-
grade), and the type of conduit (synthetic vs autologous).
All approaches have shown good overall perioperative out-
Number at Risk
Endarterectomy             27                   12                   7                     7                     4                      0
Bypass         25                   17                  10                    9                     7                      6
Combined                        10                    8                     7                     6                      3                     3
           Years Following Procedure     0                      1                    2                     3                      4                     5
 Bypass
p = 0.13
Fig 2. Kaplan-Meier estimates of freedom from recurrent stenosis
after open repair for mesenteric ischemia with endarterectomy (blue
line), bypass (red line), and combined procedures (green line).comes, with mortality of 2% to 11%, symptom improve-
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66%.2,6-11 In these studies long-term graft patency was 63%
to 90% and symptomatic recurrence occurred in 9% to 41%
p = 0.22
Number at Risk
Endarterectomy
Bypass                       29           22            15              12              9              7
Combined                14           12            11               9               6              6
                                      0              1              2                3               4              5
                                                       
37           21            15              15             12             7
Bypass
                        Years Following Procedure
Fig 3. Kaplan-Meier estimates of freedom from repeat intervention
after open repair for mesenteric ischemia with endarterectomy (blue
line), bypass (red line), and combined procedures (green line).
Table VI. Analysis of factors associated with repeat
intervention
Variable HR (95% CI) P
Univariate analysis
Age .005
Smoking .35
Diabetes mellitus .99
Renal failure .99
Hyperlipidemia .77
Cardiac history .97
Hypertension .42
Acute symptoms .03
Endarterectomy .15
Number of diseased vessels .13
Occluded vessels .04
Number of vessels repaired .94
Aortic reconstruction .99
Directionality of bypass .51
Type of conduit .47
Multivariate analysis
Age 0.94 (0.88-0.99) .04
Acute symptoms 3.27 (0.00-0.00) .11
Occluded vessels 2.68 (0.00-0.00) .14
CI, Confidence interval; HR, hazard ratio.of patients, depending on the length of follow-up. The typeof bypass did not affect survival, symptom-free survival, or
graft patency.
Reports of the use of endarterectomy have declined in the
past two decades (Table VII), with most studies focusing on
outcomes after surgical bypass. An early study by Rapp et al12
reported a 7% recurrence of symptoms in a cohort of 67 CMI
patients who received endarterectomy (n 47) or antegrade
bypass (n  20), with a mean follow-up of 4.4 years. No
comparison was made between the two groups. Cho et al8
noted a gradual decline in the use of endarterectomy in
favor of bypass. Contrary to our findings, that study did not
demonstrate that the type of revascularization predicted late
survival, graft patency, or freedom from symptom recurrence.
Failure to show any difference related to these factors is likely
because this and other small series with good outcomes were
under-powered to detect differences from treatment ap-
proaches.
Some studies have shown higher morbidity and mortality
when mesenteric revascularization was combined with aortic
reconstruction.5,10 A recent report by Atkins et al6 demon-
strated no increased morbidity or mortality for combined
procedures. In our series, reconstruction for aortic occlusive
disease was associated with increased morbidity but did not
translate into increased perioperative mortality or inferior
long-term outcomes. We therefore continue to offer com-
bined procedures when clinically warranted.
Patients presenting with acute symptoms superimposed
on CMI were associated with a higher morbidity, a higher
incidence of reintervention, and a trend toward decreased
long-term survival. Progression of mesenteric stenosis to
occlusion has been estimated to account for 20% to 50% of
acute mesenteric ischemia.17,18 English et al7 demon-
strated significantly higher perioperative mortality for pa-
tients who presented with acute-on-chronic symptoms.
Multivariate analysis identified intestinal gangrene and age
as independent predictors of early death.
Increased morbidity in some subsets of patients with
CMI paired with recent advances in endovascular technol-
ogy has focused much of the recent attention on the
potential role of percutaneous approaches to treatment. No
prospective randomized trials have been reported. Many
studies have demonstrated high technical success, low pro-
cedural morbidity.6,13-16 Kasirajan et al19 compared 28
patients undergoing percutaneous angioplasty and stent
(PTA/stent) with 85 historical controls. Morbidity and
recurrent stenosis were not different, but patients undergo-
ing PTA/stent had a higher incidence of symptom recur-
rence, prompting recommendation of operative revascular-
ization for those medically fit. Atkins et al6 reported
equivalent morbidity and mortality when comparing PTA/
stent with open repair. PTA/stent was associated with
lower primary and clinical patency compared with open
repair. Both approaches were associated with a 20% recur-
rence of symptoms, which occurred sooner with PTA/
stent repair. Although they recognized that operative repair
offers superior results for open surgical candidates, they
acknowledged that patient preference and more rapid re-
covery has driven their practice to offering PTA/stent as
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providing it does not preclude later operative repair.
Brown et al20 noted during a mean follow-up of 13
months that their stent cohort was seven times more likely
to develop restenosis, four times more likely to develop
recurrent symptoms, and 15 times more likely to require
reintervention. They concluded that percutaneous revascu-
larization may be best reserved for patients with severe
nutritional depletion or other morbidity resulting in pre-
clusive surgical risk, and may serve as a temporizing bridge
to definitive operative repair. Nearly two-thirds of our
patient cohort was alive at 5 years, suggesting that pro-
longed survival can be expected in a significant percentage
of patients with CMI and therefore providing a durable
revascularization is a relevant and desirable goal.
This study has certain limitations. It is a retrospective,
nonrandomized study reviewing two decades, a small num-
ber of patients, and multiple surgeons; therefore, it is
subject to selection bias and interpretation bias. Changes in
medical, surgical, and anesthetic care may have affected
outcomes. Differences in outcomes may be influenced by
important unmeasured or uncontrolled variables between
different groups. As a single-center study, results may not
be generally applicable or reproducible.
Symptom recurrence may be difficult to measure as a
subjective measure. Incomplete radiographic follow-up
may have reflected bias toward patients with recurrent
symptoms; patients doing well during follow-up were less
likely to undergo routine imaging. Although anatomic data
are not complete, valid conclusions can be made with respect
to protection from recurrent symptomatic visceral ischemia.
Of note, because recurrent stenosis or graft occlusionmay not
necessarily lead to recurrent mesenteric ischemia, symptom
recurrence may be a better outcome measure than patency.21
CONCLUSIONs
Our study shows that open mesenteric revasculariza-
tion can be performed with effective symptom relief, low
perioperative mortality, acceptable morbidity, and results
in excellent long-term survival. For open surgical candi-
dates, endarterectomy appears to provide the most durable
Table VII. Outcomes after open surgical revascularization
First author Patients, No.
Vessels
treated, No. Endarterectom
Present seriesa 80 134 46
Kruger,3 2007 39 67 0
Atkins,6 2007 49 88 37
English,7 2004a 58 80 9
Cho,8 2002 25 41 41
Park,4 2002 98 179 5
Jimenez,9 2002 47 92 0
Mateo,10 1999 85 130 22
McAfee,11 1992 58 119 8
Rapp,12 1986 67 111 70
aIncludes patients with acute-on-chronic symptoms.outcomes for graft patency and long-term symptom relief.Because of the uncertain long-termoutcomes of endovascular
treatment of CMI, we believe that patients without significant
comorbid conditions or limited life expectancy should be
offered open surgical repair as initial therapy for CMI.
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PhD, for his help with statistical analysis of the data.
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